8-K - Indaptus Therapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Indaptus Therapeutics entered into warrant repricing agreements on February 11, 2026, reducing the exercise price of certain warrants to $1.75 per share and securing voting commitments from holders for an upcoming special stockholder meeting. This action adjusts existing financing terms and aligns shareholder votes on key proposals.

Key Takeaways

1Company entered into warrant repricing agreements on February 11, 2026, reducing exercise prices to $1.75 per share.

2913,638 shares of common stock warrants held by Executing Holders were repriced through agreements.

3Executing Holders agreed to vote all common stock shares in favor of proposals at the February 26, 2026 special meeting.

4Board unilaterally reduced exercise prices for an additional 762,787 shares of warrants to $1.75 per share.

5Original warrant exercise prices ranged from $8.30 to $47.60 per share before repricing.

6Warrants were originally issued in financing rounds during 2024 and 2025.

Current Report Details

Event Type

Material Agreement

Securities Issuance

Exhibits On

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On February 11, 2026, Indaptus Therapeutics, Inc. (the “Company”) entered into warrant repricing agreements (the “Re

Material Agreement

$8.30$47.60$1.75$1.75

Source Document

3.02

Unregistered Sales of Equity Securities. The information under Item 1.01 of this Current Report on Form 8-K regarding the unregistered securities described ther

Securities Issuance

9.01

. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1 Form of Warrant Repricing Agreement 10.2 Form of Voting Agreement 104 Cover P

Exhibits Only

Transaction Details

Material Agreement

Agreement: Warrant Repricing Agreements
Parties: Indaptus Therapeutics, Inc. and certain warrant holders (Executing Holders)

•Reduced exercise price to $1.75 per share
•Conditional on voting agreement
•Applies to 913,638 shares of common stock warrants
•Original exercise prices ranged from $8.30 to $47.60

Exhibits (3)

10.1

EX-10.1

10.2

EX-10.2

8-K